Clinical Trial Update: High-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial compares high-dose dexamethasone plus hetrombopag versus high-dose dexamethasone alone as frontline therapy for newly diagnosed adult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Dexamethasone (high-dose) (dexamethasone)
• Hetrombopag (hetrombopag)

Snippet

Sponsor: Shandong University | Conditions: ITP - Immune Thrombocytopenia | Phase 2 | Status: UNKNOWN